Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study

被引:35
|
作者
Haworth, Annette [1 ]
Kearvell, Rachel
Greer, Peter B. [2 ]
Hooton, Ben
Denham, James W. [2 ]
Lamb, David [3 ]
Duchesne, Gillian [4 ]
Murray, Judy [3 ]
Joseph, David
机构
[1] Peter MacCallum Canc Ctr, Dept Phys Sci, Melbourne, Vic 8006, Australia
[2] Univ Newcastle, Dept Radiat Oncol, Callaghan, NSW 2308, Australia
[3] Wellington Hosp, Wellington Blood & Canc Ctr, Wellington, New Zealand
[4] Peter MacCallum Canc Ctr, Div Radiat Oncol, Melbourne, Vic, Australia
关键词
Quality assurance; Clinical trials; Set-up accuracy; Prostate; RANDOMIZED CONTROLLED-TRIAL; PROSTATE-CANCER; CONFORMAL RADIOTHERAPY; MRC RT01; VERIFICATION PROCEDURE; DOSE-RESPONSE; IRRADIATION; THERAPY; ERRORS; REPRODUCIBILITY;
D O I
10.1016/j.radonc.2008.10.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: A multi-centre clinical trial for prostate cancer patients provided an opportunity to introduce conformal radiotherapy with dose escalation. To verify adequate treatment accuracy prior to patient recruitment, centres submitted details of a set-up accuracy study (SUAS). We report the results of the SUAS, the variation in clinical practice and the strategies used to help centres improve treatment accuracy. Materials and methods: The SUAS required each of the 24 participating centres to collect data on at least 10 pelvic patients imaged on a minimum of 20 occasions. Software was provided for data collection and analysis. Support to centres was provided through educational lectures, the trial quality assurance team and an information booklet. Results: Only two centres had recently carried Out a SUAS prior to the trial opening. Systematic errors were generally smaller than those, previously reported in the literature. The questionnaire identified many differences in patient set-up, protocols. As a result of participating in this QA activity more than 65% of centres improved their treatment delivery accuracy. Conclusions: Conducting a pre-trial SUAS has led to improvement in treatment delivery accuracy in many centres. Treatment techniques and set-up accuracy varied greatly, demonstrating a need to ensure an ongoing awareness for such Studies in future trials and with the introduction of dose escalation or new technologies. Crown Copyright (C) 2008 Published by Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 90 (2009) 299-306
引用
收藏
页码:299 / 306
页数:8
相关论文
共 16 条
  • [1] Trans-tasman radiation oncology group (TROG) development 1989-2002, and results of trials
    Denham, J
    Lamb, D
    Ball, D
    Kovacev, O
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 : S72 - S72
  • [2] High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation:: A Trans-Tasman Radiation Oncology Group Study -: TROG 96:07
    Poulsen, M
    Rischin, D
    Walpole, E
    Harvey, J
    Mackintosh, J
    Ainslie, J
    Hamilton, C
    Keller, J
    Tripcony, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4371 - 4376
  • [3] T1-2 anal carcinoma requires elective inguinal radiation treatment - The results of Trans Tasman Radiation Oncology Group study TROG 99.02
    Matthews, John H. L.
    Burmeister, Bryan H.
    Borg, Martin
    Capp, Anne L.
    Joseph, David
    Thompson, Kerin M.
    Thompson, Paul I.
    Harvey, Jennifer A.
    Spry, Nigel A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 98 (01) : 93 - 98
  • [4] Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer
    Denham, James W.
    Nowitz, Michael
    Joseph, David
    Duchesne, Gillian
    Spry, Nigel A.
    Lamb, David S.
    Matthews, John
    Turner, Sandra
    Atkinson, Chris
    Tai, Keen-Hun
    Gogna, Nirdosh Kumar
    Kenny, Lizbeth
    Diamond, Terry
    Smart, Richard
    Rowan, David
    Moscato, Pablo
    Vimieiro, Renato
    Woodfield, Richard
    Lynch, Kevin
    Delahunt, Brett
    Murray, Judy
    D'Este, Cate
    McElduff, Patrick
    Steigler, Allison
    Kautto, Allison
    Ball, Jean
    [J]. BJU INTERNATIONAL, 2014, 114 (03) : 344 - 353
  • [5] Randomized trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01): A Trans-Tasman Radiation Oncology Group study.
    Rischin, Danny
    King, Madeleine T.
    Kenny, Lizbeth M.
    Porceddu, Sandro
    Wratten, Christopher
    Macann, Andrew
    Jackson, James E.
    Bressel, Mathias
    Herschtal, Alan
    Richard, Fisher
    Fua, Tsien
    Lin, Charles
    Liu, Chen-Shin
    Hughes, Brett Gordon Maxwell
    McGrath, Margie
    McDowell, Lachlan
    Corry, June
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01)-A Trans-Tasman Radiation Oncology Group Study
    Rischin, Danny
    King, Madeleine
    Kenny, Lizbeth
    Porceddu, Sandro
    Wratten, Christopher
    Macann, Andrew
    Jackson, James E.
    Bressel, Mathias
    Herschtal, Alan
    Fisher, Richard
    Fua, Tsien
    Lin, Charles
    Liu, Chen
    Hughes, Brett G. M.
    McGrath, Margaret
    McDowell, Lachlan
    Corry, June
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (04): : 876 - 886
  • [7] Risk and response adapted treatment for early stage Hodgkin's lymphoma (ESHL): Preliminary results of an Australasian Leukaemia & Lymphoma Group/Trans-Tasman Radiation Oncology Group study.
    Wirth, A
    Grigg, A
    Wolf, M
    Davis, S
    Hertzberg, M
    Joseph, D
    Johnson, C
    Weih, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 565S - 565S
  • [8] Can We Predict Plan Quality for External Beam Partial Breast Irradiation: Results of a Multicenter Feasibility Study (Trans Tasman Radiation Oncology Group Study 06.02)
    Kron, Tomas
    Willis, David
    Link, Emma
    Lehman, Margot
    Campbell, Gillian
    O'Brien, Peter
    Chua, Boon
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (04): : 817 - 824
  • [9] SIMULTANEOUS ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER - TOXICITY AND DOSE MODIFICATION - A TRANS-TASMAN RADIATION ONCOLOGY GROUP MULTI-INSTITUTION STUDY
    DENHAM, JW
    HAMILTON, CS
    CHRISTIE, D
    OBRIEN, M
    BONAVENTURA, A
    STEWART, JF
    ACKLAND, SP
    LAMB, DS
    SPRY, NA
    DADY, P
    ATKINSON, CH
    WYNNE, C
    JOSEPH, DJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (02): : 305 - 313
  • [10] The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: A prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)
    Ball, David L.
    Fisher, Richard J.
    Burmeister, Bryan H.
    Poulsen, Michael G.
    Graham, Peter H.
    Penniment, Michael G.
    Vinod, Shalini K.
    Krawitz, Hedley E.
    Joseph, David J.
    Wheeler, Greg C.
    McClure, Bev E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 106 (03) : 305 - 311